ArticleJAMA network open2026

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis.

Caroline Kellogg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.